{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:18:42Z","timestamp":1794809922094,"version":"4.9.1"},"reference-count":66,"publisher":"Bentham Science Publishers Ltd.","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMIR"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction\/ Background:<\/jats:title>\n                    <jats:p>Advanced pulmonary carcinoma frequently metastasises to the chest cavity, resulting in malignant pleural effusion (PE). Consequently, when PE is\nof pulmonary origin, diagnosis is generally straightforward. However, when PE originates from non-pulmonary sites, diagnosis becomes more\nchallenging. This study aims to evaluate the diagnostic utility of combining cell block immunohistochemistry (IHC) with imaging modalities in\ndiagnostically challenging cases of PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>We collected PE data from difficult-to-diagnose cases admitted to Nantong Tumor Hospital from January to December 2024. Malignant PE of nonpulmonary\norigin and benign PE were defined as difficult cases. For each patient, pleural fluid underwent liquid-based cytology, cell block IHC,\nand imaging to differentiate between benign and malignant etiologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among the 23 patients included, 9 presented with benign PE and 14 with malignant PE.\n1. Benign pleural fluid cases: IHC analysis of cell blocks revealed proliferating mesothelial cells. CT identified six cases of PE, including five with\nconcomitant pneumonia. PET-CT was performed in three patients; results indicated pneumonia in two cases and no significant abnormal uptake in\nthe remaining case.\n2. Malignant PE cases: The primary origins were the digestive system (eight cases), breast (five cases), and gynecological system (one case).\n3. Cases of gastrointestinal origin: One patient was diagnosed with a gallbladder tumor via PET-CT; one with a pancreatic tail tumor via CT; two\nwith colon malignancy via CT; and one with gastric cancer via CT. The remaining three cases had their primary lesions surgically removed, and\nCT revealed abdominal metastases.\n4. Cases of breast origin (five cases): CT imaging showed lung metastasis in three cases, liver metastasis in two cases, and bone metastasis in two\ncases.\n5. Case of gynecological origin: CT showed PE and lung metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>IHC can help determine the origin of PE. However, IHC sometimes provides only a general direction, such as suggesting that malignant cells arise\nin the digestive tract. The digestive tract includes a wide range of organs (e.g., gastrointestinal tract, liver, gallbladder, pancreas). Therefore, to\naccurately localize the source of PE to specific organs or tissues, imaging examination is indispensable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Cell block IHC is effective for determining the origin of PE, while imaging is useful for localization and identification of metastatic lesions.\nCombining these modalities helps differentiate between benign and malignant etiologies in difficult-to-diagnose PE cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734056446228260706113151","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:22:41Z","timestamp":1784953361000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Diagnostic Value of Cell Block Immunohistochemistry Combined with Imaging For Difficult Pleural Effusion"],"prefix":"10.2174","volume":"22","author":[{"given":"Hui","family":"Yu","sequence":"first","affiliation":[{"name":"Translational Medicine Center, Nantong Tumor Research Institute; Affiliated Tumor Hospital of Nantong University, Nantong Tumor Hospital, No. 30, North Tong-yang Road, Pingchao Town, Tongzhou District, Nantong, Jiangsu 226361, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Yong","family":"Shen","sequence":"additional","affiliation":[{"name":"Translational Medicine Center, Nantong Tumor Research Institute; Affiliated Tumor Hospital of Nantong University, Nantong Tumor Hospital, No. 30, North Tong-yang Road, Pingchao Town, Tongzhou District, Nantong, Jiangsu 226361, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"230145","DOI":"10.1183\/20734735.0145-2023","volume":"19","author":"Piggott L.M.","year":"2023","unstructured":"Piggott L.M.; Hayes C.; Greene J.; Fitzgerald D.B.; Malignant pleural disease. Breathe  2023,19(4),230145","journal-title":"Breathe"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3390\/genes13112159","volume":"13","author":"Shojaee S.","year":"2022","unstructured":"Shojaee S.; Romano G.; Sanchez T.M.; Yermakhanova G.; Saviana M.; Le P.; Nigita G.; Calore F.; Guthrie R.; Hess K.; Kang L.; Swift-Scanlan T.; Graham J.T.; Rahman N.M.; Nana-Sinkam P.S.; Acunzo M.; Extracellular vesicle MicroRNA in malignant pleural effusion. Genes  2022,13(11),2159","journal-title":"Genes"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12931-024-02684-7","volume":"25","author":"Gonnelli F.","year":"2024","unstructured":"Gonnelli F.; Hassan W.; Bonifazi M.; Pinelli V.; Bedawi E.O.; Porcel J.M.; Rahman N.M.; Mei F.; Malignant pleural effusion: Current understanding and therapeutic approach. Respir Res  2024,25(1),47","journal-title":"Respir Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3238\/arztebl.m2022.0229","volume":"119","author":"Hofmann H.S.","year":"2022","unstructured":"Hofmann H.S.; Scheule A.M.; Markowiak T.; Ried M.; The treatment of malignant pleural effusion with permanent indwelling pleural catheters. Dtsch Arztebl Int  2022,119(35-36),595-600","journal-title":"Dtsch Arztebl Int"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/NHH.0000000000001023","volume":"39","author":"Vrtis M.C.","year":"2021","unstructured":"Vrtis M.C.; DeCesare E.; Day R.S.; Indwelling pleural catheters for malignant pleural effusion. Home Healthc Now  2021,39(6),302-309","journal-title":"Home Healthc Now"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ijrobp.2010.03.046","volume":"80","author":"Shirai K.","year":"2011","unstructured":"Shirai K.; Tamaki Y.; Kitamoto Y.; Murata K.; Satoh Y.; Higuchi K.; Nonaka T.; Ishikawa H.; Katoh H.; Takahashi T.; Nakano T.; Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys  2011,80(4),1002-1007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.remnie.2023.05.001","volume":"42","author":"Budak A.","year":"2023","unstructured":"Budak A.; Yanarate\u015f A.; Budak E.; The contribution of PET\/CT to the differentiation of benign and malignant pleural effusion in patients with ovarian carcinoma. Rev Esp Med Nucl Imagen Mol  2023,42(6),353-358","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1186\/s12885-021-09041-7","volume":"21","author":"Zhang Y.T.","year":"2021","unstructured":"Zhang Y.T.; Zhong X.; Gao Y.; Chang J.; Evaluation of IL-2 and Dexamethasone intracavitary injection on the management of malignant effusion in children with solid tumors or lymphoma. BMC Cancer  2021,21(1),1302","journal-title":"BMC Cancer"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000517910","volume":"101","author":"Ellayeh M.","year":"2022","unstructured":"Ellayeh M.; Bedawi E.; Banka R.; Sundaralingam A.; George V.; Kanellakis N.; Hallifax R.; Abdelwahab H.; Rezk N.; Hewidy A.; Ali R.; Wrightson J.; Rahman N.; Objective thoracoscopic criteria in differentiation between benign and malignant pleural effusions. Respiration  2022,101(1),46-56","journal-title":"Respiration"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/dc.23567","volume":"44","author":"Dadhich H.","year":"2016","unstructured":"Dadhich H.; Toi P.C.; Siddaraju N.; Sevvanthi K.; A comparative analysis of conventional cytopreparatory and liquid based cytological techniques (Sure Path) in evaluation of serous effusion fluids. Diagn Cytopathol  2016,44(11),874-879","journal-title":"Diagn Cytopathol"},{"key":"ref=11","first-page":"149","volume":"54","author":"Chen C.J.","year":"1994","unstructured":"Chen C.J.; Chang S.C.; Tseng H.H.; Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions. Zhonghua Yi Xue Za Zhi  1994,54(3),149-155","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref=12","first-page":"5810","volume":"7","author":"Yan J.","year":"2014","unstructured":"Yan J.; Wei Q.; Jian W.; Liu J.; Tang H.; Ge J.; Zhou J.; Zhao T.; A fine decision tree consisted of CK5\/6, IMP3 and TTF1 for cytological diagnosis among reactive mesothelial cells, metastatic adenocarcinoma of lung and non-lung origin in pleural effusion. Int J Clin Exp Pathol  2014,7(9),5810-5818","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2147\/CMAR.S462951","volume":"16","author":"Liu C.","year":"2024","unstructured":"Liu C.; He Y.; Luo J.; Application of chest CT imaging feature model in distinguishing squamous cell carcinoma and adenocarcinoma of the lung. Cancer Manag Res  2024,16,547-557","journal-title":"Cancer Manag Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000328793","volume":"34","author":"Kim B.S.","year":"2011","unstructured":"Kim B.S.; Kim I.J.; Kim S.J.; Pak K.; Kim K.; Predictive value of F-18 FDG PET\/CT for malignant pleural effusion in non-small cell lung cancer patients. Oncol Res Treat  2011,34(6),298-303","journal-title":"Oncol Res Treat"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0720-048X(01)00426-0","volume":"41","author":"Metintas M.","year":"2002","unstructured":"Metintas M.; Ucgun I.; Elbek O.; Erginel S.; Metintas S.; Kolsuz M.; Harmanci E.; Alatas F.; Hillerdal G.; Ozkan R.; Kaya T.; Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol  2002,41(1),1-9","journal-title":"Eur J Radiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/MNM.0000000000001375","volume":"42","author":"\u00d6zmen \u00d6.","year":"2021","unstructured":"\u00d6zmen \u00d6.; Tatci E.; Demir\u00f6z \u015e.M.; Tazeler Z.; Demira\u011f F.; Is 18F-FDG PET\/CT capable of differential diagnosis from tuberculous pleurisy from malignant mesothelioma? Nucl Med Commun  2021,42(6),672-677","journal-title":"Nucl Med Commun"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/ppul.27133","volume":"59","author":"Akay M.A.","year":"2024","unstructured":"Akay M.A.; Tatar O.C.; Tatar E.; Ta\u011fman B.N.; Metin S.; Varl\u0131kl\u0131 O.; XRAInet: AI-based decision support for pneumothorax and pleural effusion management. Pediatr Pulmonol  2024,59(11),2809-2814","journal-title":"Pediatr Pulmonol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1513\/AnnalsATS.202305-410OC","volume":"21","author":"Kim N.Y.","year":"2024","unstructured":"Kim N.Y.; Jang B.; Gu K.M.; Park Y.S.; Kim Y.G.; Cho J.; Differential diagnosis of pleural effusion using machine learning. Ann Am Thorac Soc  2024,21(2),211-217","journal-title":"Ann Am Thorac Soc"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00383-023-05609-5","volume":"40","author":"Tatar O.C.","year":"2023","unstructured":"Tatar O.C.; Akay M.A.; Metin S.; DraiNet: AI-driven decision support in pneumothorax and pleural effusion management. Pediatr Surg Int  2023,40(1),30","journal-title":"Pediatr Surg Int"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.25259\/Cytojournal_40_2023","volume":"21","author":"Mathew J.K.","year":"2024","unstructured":"Mathew J.K.; Rajan G.N.; Kunju A.K.; Diagnostic analysis of pleural fluid cell blocks using relevant immunohistochemical markers in clinically suspicious cases of malignancy. Cytojournal  2024,21,8","journal-title":"Cytojournal"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/dc.20986","volume":"37","author":"Kim J.H.","year":"2009","unstructured":"Kim J.H.; Kim G.E.; Choi Y.D.; Lee J.S.; Lee J.H.; Nam J.H.; Choi C.; Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks. Diagn Cytopathol  2009,37(4),258-261","journal-title":"Diagn Cytopathol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1159\/000337439","volume":"56","author":"Liu L.","year":"2012","unstructured":"Liu L.; Cohen C.; Siddiqui M.T.; Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid. Acta Cytol  2012,56(4),425-430","journal-title":"Acta Cytol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/cncy.21393","volume":"122","author":"Shield P.W.","year":"2014","unstructured":"Shield P.W.; Papadimos D.J.; Walsh M.D.; GATA3: A promising marker for metastatic breast carcinoma in serous effusion specimens. Cancer Cytopathol  2014,122(4),307-312","journal-title":"Cancer Cytopathol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.18999\/nagjms.82.2.225","volume":"82","author":"Maseki Z.","year":"2020","unstructured":"Maseki Z.; Kajiyama H.; Nishikawa E.; Satake T.; Misawa T.; Kikkawa F.; Is cell block technique useful to predict histological type in patients with ovarian mass and\/or body cavity fluids? Nagoya J Med Sci  2020,82(2),225-235","journal-title":"Nagoya J Med Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2303.2007.00482.x","volume":"19","author":"Shield P.W.","year":"2008","unstructured":"Shield P.W.; Koivurinne K.; The value of calretinin and cytokeratin 5\/6 as markers for mesothelioma in cell block preparations of serous effusions. Cytopathology  2008,19(4),218-223","journal-title":"Cytopathology"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1159\/000443760","volume":"59","author":"Chen L.","year":"2015","unstructured":"Chen L.; Zhang J.; Cui D.; Liu D.; Cytological diagnosis of T lymphoblastic leukemia\/lymphoma in patients with pleural effusion as an initial clinical presentation: Two case reports of an algorithmic approach using complete immunohistochemical phenotyping. Acta Cytol  2015,59(6),485-492","journal-title":"Acta Cytol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.21037\/jtd-22-842","volume":"14","author":"Wei S.","year":"2022","unstructured":"Wei S.; Shao J.; Wang J.; Zhao T.; Liu J.; Shen X.; Wang Y.; Chen H.; Wang G.; EHD2 inhibits the invasive ability of lung adenocarcinoma and improves the prognosis of patients. J Thorac Dis  2022,14(7),2652-2664","journal-title":"J Thorac Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/pro6.70012","volume":"9","author":"Wu P.","year":"2025","unstructured":"Wu P.; Li C.; Wei Z.; Meng X.; Radiotherapy after neoadjuvant immunochemotherapy in unresectable stage iii non-small cell lung carcinoma: A novel therapeutic approach? Precis Radiat Oncol  2025,9(2),143-144","journal-title":"Precis Radiat Oncol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/dc.23442","volume":"44","author":"El Hag M.","year":"2016","unstructured":"El Hag M.; Schmidt L.; Roh M.; Michael C.W.; Utility of TTF-1 and Napsin-A in the work-up of malignant effusions. Diagn Cytopathol  2016,44(4),299-304","journal-title":"Diagn Cytopathol"},{"key":"ref=30","first-page":"95","volume":"62","author":"Ensani F.","year":"2011","unstructured":"Ensani F.; Nematizadeh F.; Irvanlou G.; Accuracy of immunohistochemistry in evaluation of malignant pleural and peritoneal effusions. Pol J Pathol  2011,62(2),95-100","journal-title":"Pol J Pathol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1515\/pp-2017-0014","volume":"2","author":"El Hag M.I.","year":"2017","unstructured":"El Hag M.I.; Hag A.M.; Ha J.P.; Michael C.W.; Comparison of GATA-3, mammaglobin, GCDFP-15 expression in breast carcinoma in serous effusions: A cell-block micro-array study. Pleura Peritoneum  2017,2(3),143-148","journal-title":"Pleura Peritoneum"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/pro6.1241","volume":"8","author":"Xu X.","year":"2024","unstructured":"Xu X.; Yin Y.; Zhang L.; Wang D.; Zhou Y.; Li Q.; Research progress of cardiotoxicity caused by radiotherapy in breast cancer. Precis Radiat Oncol  2024,8(3),153-158","journal-title":"Precis Radiat Oncol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/apm.12854","volume":"126","author":"Dabir P.D.","year":"2018","unstructured":"Dabir P.D.; Svanholm H.; Christiansen J.J.;  2 is a supplementary immunohistochemical marker to  2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary. Acta Pathol Microbiol Scand Suppl  2018,126(6),494-500","journal-title":"Acta Pathol Microbiol Scand Suppl"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/diagnostics12030757","volume":"12","author":"Choi H.B.","year":"2022","unstructured":"Choi H.B.; Pyo J.S.; Son S.; Kim K.; Kang G.; Diagnostic and prognostic roles of CDX2 immunohistochemical expression in colorectal cancers. Diagnostics  2022,12(3),757","journal-title":"Diagnostics"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e230079","DOI":"10.1148\/rg.230079","volume":"44","author":"Yamada A.","year":"2024","unstructured":"Yamada A.; Taiji R.; Nishimoto Y.; Itoh T.; Marugami A.; Yamauchi S.; Minamiguchi K.; Yanagawa M.; Tomiyama N.; Tanaka T.; Pictorial review of pleural disease: Multimodality imaging and differential diagnosis. Radiographics  2024,44(4),e230079","journal-title":"Radiographics"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1177\/1535370220936150","volume":"245","author":"Shen Z.","year":"2020","unstructured":"Shen Z.; Shao J.; Zhang J.; Qu W.; Ultrasound cavitation enhanced chemotherapy: In vivo research and clinical application. Exp Biol Med  2020,245(14),1200-1212","journal-title":"Exp Biol Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"6977","DOI":"10.3390\/jcm12226977","volume":"12","author":"Cohen S.E.","year":"2023","unstructured":"Cohen S.E.; Betancourt J.; Soo Hoo G.W.; Pleural uptake patterns in fluorodeoxyglucose-positron emission tomography (FDG-PET) scans improve the identification of malignant pleural effusions. J Clin Med  2023,12(22),6977","journal-title":"J Clin Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3760\/cma.j.cn112151-20240120-00054","volume":"53","author":"Sun M.J.","year":"2024","unstructured":"Sun M.J.; Liu L.T.; Li C.Y.; Liu D.G.; Chen L.; Application of cell blocks to assist in precise cytological diagnosis of serous effusion. Zhonghua Bing Li Xue Za Zhi  2024,53(8),830-836","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/01.MP.0000067683.84284.66","volume":"16","author":"Lee M.J.","year":"2003","unstructured":"Lee M.J.; Lee H.S.; Kim W.H.; Choi Y.; Yang M.; Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol  2003,16(5),403-410","journal-title":"Mod Pathol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/dc.23607","volume":"44","author":"Francis I.M.","year":"2016","unstructured":"Francis I.M.; Alath P.; George S.S.; Jaragh M.; Al Jassar A.; Kapila K.; Metastatic breast carcinoma in pleural fluid: Correlation of receptor and HER2 status with the primary carcinoma\u2014a pilot study. Diagn Cytopathol  2016,44(12),980-986","journal-title":"Diagn Cytopathol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4103\/IJPM.IJPM_858_19","volume":"63","author":"Rekhi B.","year":"2020","unstructured":"Rekhi B.; Karmarkar S.; Gupta C.; Deodhar K.; Menon S.; Pathuthara S.; Maheshwari A.; Shylasree T.S.; Gupta S.; Evaluation of cell blocks from effusion specimens in Gynecologic Oncopathology: An experience of 220 cases, diagnosed at a Tertiary Cancer Referral Center. Indian J Pathol Microbiol  2020,63(3),427-434","journal-title":"Indian J Pathol Microbiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"e19495","DOI":"10.7717\/peerj.19495","volume":"13","author":"Hu X.","year":"2025","unstructured":"Hu X.; Li Y.; Cai J.; Wang P.; The role of  F-FDG PET\/CT in patients with serous cavity effusion of undetermined origin: A retrospective clinical study. PeerJ  2025,13,e19495","journal-title":"PeerJ"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/dc.24804","volume":"49","author":"Xu Y.","year":"2021","unstructured":"Xu Y.; Hu A.Y.; Wang S.M.; Wang Q.; Pan Y.C.; Zhang S.H.; A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology. Diagn Cytopathol  2021,49(9),997-1007","journal-title":"Diagn Cytopathol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13000-022-01241-4","volume":"17","author":"Zhu Y.","year":"2022","unstructured":"Zhu Y.; Ren W.; Wang Q.; Jin H.; Guo Y.; Lin D.; A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: A report of 3633 cases in an oncological center. Diagn Pathol  2022,17(1),56","journal-title":"Diagn Pathol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/dc.24440","volume":"49","author":"Lobo C.","year":"2021","unstructured":"Lobo C.; Costa J.; Petronilho S.; Monteiro P.; Le\u00e7a L.; Schmitt F.; Cytohistological correlation in serous effusions using the newly proposed international system for reporting serous fluid cytopathology: Experience of an oncological center. Diagn Cytopathol  2021,49(5),596-605","journal-title":"Diagn Cytopathol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/cncy.22783","volume":"132","author":"Lu C.H.","year":"2024","unstructured":"Lu C.H.; Liu C.Y.; Jhuang J.Y.; Chen C.C.; Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the international system for reporting serous fluid cytopathology: A multi-institutional study in Taiwan. Cancer Cytopathol  2024,132(3),169-178","journal-title":"Cancer Cytopathol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.25259\/CMAS_02_04_2021","volume":"18","author":"Shidham V.B.","year":"2021","unstructured":"Shidham V.B.; Diagnostic pitfalls in effusion fluid cytology. Cytojournal  2021,18,33","journal-title":"Cytojournal"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1159\/000540866","volume":"17","author":"Putra A.","year":"2024","unstructured":"Putra A.; Gerwindrawan A.; Budiono E.; Purwanto Utomo B.; Afifah N.H.; Sumpono A.S.B.; Pradjatmo H.; Purwanto I.; A case of CUP with malignant pleural effusion: Overcoming diagnostic and therapeutic hurdles with chemotherapy. Case Rep Oncol  2024,17(1),1194-1200","journal-title":"Case Rep Oncol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"E80","DOI":"10.1002\/dc.25445","volume":"53","author":"Hawes J.","year":"2025","unstructured":"Hawes J.; Strange T.; Iqbal F.; Clement C.G.; Metastatic hobnail papillary thyroid carcinoma initially diagnosed by pleural effusion: Case report of a rare and intriguing entity. Diagn Cytopathol  2025,53(5),E80-E86","journal-title":"Diagn Cytopathol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13019-025-03539-y","volume":"20","author":"Liang H.","year":"2025","unstructured":"Liang H.; Li X.; Wei Z.; Elevated tumour markers in the pleural effusion of a patient with spontaneous esophageal rupture: A rare case report. J Cardiothorac Surg  2025,20(1),301","journal-title":"J Cardiothorac Surg"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1111\/aas.70042","volume":"69","author":"Olesen A.S.O.","year":"2025","unstructured":"Olesen A.S.O.; Miger K.; Thune J.J.; Nielsen O.W.; Jakobsen J.C.; Grand J.; Diagnostic methods for pulmonary congestion and pleural effusion: A protocol for a systematic review and meta-analysis. Acta Anaesthesiol Scand  2025,69(6),e70042","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1515\/pp-2020-0152","volume":"6","author":"Porcel J.M.","year":"2021","unstructured":"Porcel J.M.; Murata P.; Porcel L.; Bielsa S.; Pardina M.; Salud A.; Prevalence, clinical characteristics, and outcome of pleural effusions in ovarian cancer. Pleura Peritoneum  2021,6(2),75-81","journal-title":"Pleura Peritoneum"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1055\/s-0043-1769096","volume":"44","author":"Porcel J.M.","year":"2023","unstructured":"Porcel J.M.; Expert review on contemporary management of common benign pleural effusions. Semin Respir Crit Care Med  2023,44(4),477-490","journal-title":"Semin Respir Crit Care Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/MCP.0000000000000574","volume":"25","author":"Aboudara M.","year":"2019","unstructured":"Aboudara M.; Maldonado F.; Indwelling pleural catheters for benign pleural effusions. Curr Opin Pulm Med  2019,25(4),369-373","journal-title":"Curr Opin Pulm Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1200\/OP.24.00387","volume":"21","author":"Munavvar M.","year":"2025","unstructured":"Munavvar M.; Bodtger U.; Carus A.; Cordovilla R.; Naik S.; Salud A.; Porcel J.M.; Current trends in treating malignant pleural effusion: Evidence, guidelines, and best practice recommendations. JCO Oncol Pract  2025,21(6),759-765","journal-title":"JCO Oncol Pract"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10637-024-01424-4","volume":"42","author":"Zhao Y.","year":"2024","unstructured":"Zhao Y.; Mei T.; Na F.; Tian X.; Ao R.; Long X.; Luo Q.; Duan P.; Zhu J.; Wang Y.; Huang M.; Liu Y.; Gong Y.; First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab? Invest New Drugs  2024,42(2),196-206","journal-title":"Invest New Drugs"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3760\/cma.j.cn112147-20230902-00126","volume":"46","year":"2023","unstructured":"Chinese expert consensus on treatment of malignant pleural effusion (2023 Edition). Zhonghua Jie He He Hu Xi Za Zhi  2023,46(12),1189-1203","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1186\/s12885-016-2935-4","volume":"16","author":"Biaoxue R.","year":"2016","unstructured":"Biaoxue R.; Xiguang C.; Hua L.; Wenlong G.; Shuanying Y.; Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: A systematic evaluation and meta-analysis. BMC Cancer  2016,16(1),888","journal-title":"BMC Cancer"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12957-025-03887-y","volume":"23","author":"Han X.","year":"2025","unstructured":"Han X.; Qin S.; Liu S.; Li Z.; Intracavitary perfusion with bevacizumab plus cisplatin versus cisplatin alone for malignant pleural effusion in lung cancer patients: A meta-analysis of randomized controlled trials. World J Surg Oncol  2025,23(1),278","journal-title":"World J Surg Oncol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1080\/07853890.2022.2071977","volume":"54","author":"Xiang Z.","year":"2022","unstructured":"Xiang Z.; Deng X.; He W.; Yang Q.; Ni L.; Dehghan Shasaltaneh M.; Maghsoudloo M.; Yang G.; Wu J.; Imani S.; Wen Q.; Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy. Ann Med  2022,54(1),1357-1371","journal-title":"Ann Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1016\/j.jtcvs.2020.11.160","volume":"163","author":"Ekeke C.N.","year":"2022","unstructured":"Ekeke C.N.; Russell K.L.; Murthy P.; Guo Z.S.; Soloff A.C.; Weber D.; Pan W.; Lotze M.T.; Dhupar R.; Intrapleural interleukin-2-expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural disease. J Thorac Cardiovasc Surg  2022,163(4),e313-e328","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1158\/1078-0432.CCR-07-0403","volume":"13","author":"Sterman D.H.","year":"2007","unstructured":"Sterman D.H.; Recio A.; Carroll R.G.; Gillespie C.T.; Haas A.; Vachani A.; Kapoor V.; Sun J.; Hodinka R.; Brown J.L.; Corbley M.J.; Parr M.; Ho M.; Pastan I.; Machuzak M.; Benedict W.; Zhang X.; Lord E.M.; Litzky L.A.; Heitjan D.F.; June C.H.; Kaiser L.R.; Vonderheide R.H.; Albelda S.M.; Kanther M.; A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: High rate of antitumor immune responses. Clin Cancer Res  2007,13(15),4456-4466","journal-title":"Clin Cancer Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000329817","volume":"55","author":"Nasser H.","year":"2011","unstructured":"Nasser H.; Kuntzman T.J.; Pleural effusion in women with a known adenocarcinoma: The role of immunostains in uncovering another hidden primary tumor. Acta Cytol  2011,55(5),438-444","journal-title":"Acta Cytol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s11604-021-01155-z","volume":"39","author":"Simsek F.S.","year":"2021","unstructured":"Simsek F.S.; Yuksel D.; Yaylali O.; Aslan H.S.; K\u0131l\u0131\u00e7arslan E.; Bir F.; Arslan M.; Can F.E.; Ugurlu E.; Can PET\/CT be used more effectively in pleural effusion evaluation? Jpn J Radiol  2021,39(12),1186-1194","journal-title":"Jpn J Radiol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e15734056314192","DOI":"10.2174\/0115734056314192241002075034","volume":"20","author":"Wang N.","year":"2024","unstructured":"Wang N.; Zhao Z.; Duan Z.; Xie F.; Predicting immune checkpoint inhibitor-related pneumonitis via computed tomography and whole-lung analysis deep learning. Curr Med Imaging  2024,20,e15734056314192","journal-title":"Curr Med Imaging"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4274\/ThoracResPract.2025.2025-6-2","volume":"27","author":"Karata\u015f F.","year":"2026","unstructured":"Karata\u015f F.; Dikensoy \u00d6.; Artificial Intelligence in pleural diseases: Current applications and next steps. Thorac Res Pract  2026,27(1),57-67","journal-title":"Thorac Res Pract"}],"container-title":["Current Medical Imaging Formerly Current Medical Imaging Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/256422","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/256422\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/256422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:47:22Z","timestamp":1794808042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/256422\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":66,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734056446228260706113151","relation":{},"ISSN":["1573-4056"],"issn-type":[{"value":"1573-4056","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-10-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15734056446228"}}